Market Indices
Latest News
 |
| ||
| ||
| ||
|
Price Targets
Mark Smith from Lake Street issued a price target of $4.00 for STKS on 2026-01-16 13:37:24.The adjusted price target was set to $4.00.At the time of the announcement,
January 16, 2026 STKS 3.41%
Kelsey Goodwin from Piper Sandler issued a price target of $8.00 for BDTX on 2026-01-16 11:54:48.The adjusted price target was set to $8.00.At the time of the announcement,
January 16, 2026 BDTX -4.49%
Justin Crowley from Piper Sandler issued a price target of $65.00 for UNTY on 2026-01-15 11:41:21.The adjusted price target was set to $65.00.At the time of the announcement,
January 15, 2026 UNTY -2.31%
from Northland Securities issued a price target of $24.00 for ISSC on 2026-01-14 14:21:33.The adjusted price target was set to $24.00.At the time of the announcement, ISSC...
January 14, 2026 ISSC 2.25%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| TYGO Tigo Energy, Inc. | 2.95
31.00% | ||||||||||||||||||
| CTMX CytomX Therapeutics, Inc. | 5.45
28.12% | ||||||||||||||||||
| SJ Scienjoy Holding Corporat | 0.88
22.87% | ||||||||||||||||||
| TLSA Tiziana Life Sciences Ltd | 1.68
15.86% | ||||||||||||||||||
| ORGNW Origin Materials Inc Warr | 0.00
14.63% | ||||||||||||||||||
| MYPSW MYPSW | 0.01
13.79% | ||||||||||||||||||
| KOPN Kopin Corporation | 3.37
13.68% | ||||||||||||||||||
| CRVS Corvus Pharmaceuticals, I | 8.05
12.75% | ||||||||||||||||||
Annual/Quarterly Reports Summary
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
November 6, 2024 AIP 1.38%
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
November 6, 2024 EOSEW -34.96%
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
November 6, 2024 EOSE 2.55%
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
November 5, 2024 STOK -1.33%
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
November 5, 2024 BSVN 2.66%